Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

Abstract Background Detection of specific immune responses against cancer/testis antigen NY-ESO-1 was recently reported in patients with adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-infected asymptomatic carriers (ACs). However, the relationship of the respons...

Full description

Bibliographic Details
Main Authors: Yasuo Shiohama, Tadasuke Naito, Toshio Matsuzaki, Reiko Tanaka, Takeaki Tomoyose, Hiroshi Takashima, Takuya Fukushima, Yuetsu Tanaka, Mineki Saito
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Virology Journal
Subjects:
HTLV-1
NY-ESO-1
ATL
HAM/TSP
Monoclonal antibody
ELISA
Online Access:http://link.springer.com/article/10.1186/s12985-017-0802-9

Internet

http://link.springer.com/article/10.1186/s12985-017-0802-9

Similar Items